## **Core Concept**
Thromboasthenia, also known as Glanzmann's thromboasthenia, is a bleeding disorder characterized by a defect in platelet function. It is primarily associated with abnormalities in platelet aggregation. The underlying issue in this condition relates to the platelet membrane glycoproteins.

## **Why the Correct Answer is Right**
The correct answer, , refers to Glycoprotein IIb/IIIa (GP IIb/IIIa), also known as integrin αIIbβ3. This complex plays a crucial role in platelet aggregation by acting as a receptor for fibrinogen and von Willebrand factor, facilitating platelet-platelet bridging. In Glanzmann's thromboasthenia, there is a deficiency or dysfunction of GP IIb/IIIa, leading to impaired platelet aggregation and a significant bleeding tendency.

## **Why Each Wrong Option is Incorrect**
- **Option A:** - This option is incorrect because while other glycoproteins are important on the platelet surface, the specific defect in thromboasthenia involves GP IIb/IIIa.
- **Option B:** - This is incorrect as it does not accurately represent the specific glycoprotein complex defective in thromboasthenia.
- **Option C:** - This option is incorrect because it does not correspond to the GP IIb/IIIa complex.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients with Glanzmann's thromboasthenia often present with mucocutaneous bleeding, such as purpura, epistaxis, and gingival bleeding, and may have a normal platelet count but abnormal platelet function. Laboratory diagnosis typically involves platelet aggregation studies showing impaired aggregation in response to various agonists.

## **Correct Answer:** . Glycoprotein IIb/IIIa